Exact Mass: 331.15319860000005

Exact Mass Matches: 331.15319860000005

Found 130 metabolites which its exact mass value is equals to given mass value 331.15319860000005, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

   

Pitolisant hydrochloride

Pitolisant hydrochloride

C17H27Cl2NO (331.1469592)


C78272 - Agent Affecting Nervous System Pitolisant hydrochloride is a potent and selective nonimidazole inverse agonist at the recombinant human histamine H3 receptor (Ki=0.16 nM).

   

Alitame

3-Amino-3-({1-[(2,2,4,4-tetramethylthietan-3-yl)-C-hydroxycarbonimidoyl]ethyl}-C-hydroxycarbonimidoyl)propanoate

C14H25N3O4S (331.15656900000005)


Alitame is a sweetening agent. It is intensely sweet, approximately 2000 times sweeter than sucrose. Its use is currently (1999) permitted in Australia, New Zealand, Indonesia and China. Alitame is an artificial sweetener developed by Pfizer in the early 1980s and currently marketed in some countries under the brand name Aclame. Like aspartame, alitame is an aspartic acid-containing dipeptide. Most dipeptides are not sweet, but the unexpected discovery of aspartame in 1965 led to a search for similar compounds that shared its sweetness. Alitame is one such second-generation dipeptide sweetener. Neotame, developed by the owners of the NutraSweet brand, is another. Sweetening agent. Intensely sweet, approx. 2000 x sucrose. Use currently (1999) permitted in Australia, New Zealand, Indonesia and China

   

6-Hydroxyoct-2-enedioylcarnitine

3-[(7-carboxy-6-hydroxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


6-hydroxyoct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyoct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyoct-3-enedioylcarnitine

3-[(7-carboxy-6-hydroxyhept-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


6-hydroxyoct-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyoct-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-hydroxyoct-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-hydroxyoct-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoct-3-enedioylcarnitine

3-[(7-carboxy-7-hydroxyhept-3-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


7-hydroxyoct-3-enedioylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoct-3-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoct-3-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-hydroxyoct-3-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyoct-4-enedioylcarnitine

3-[(7-carboxy-7-hydroxyhept-4-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


7-hydroxyoct-4-enedioylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyoct-4-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-hydroxyoct-4-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-hydroxyoct-4-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyoct-2-enedioylcarnitine

3-[(7-carboxy-5-hydroxyhept-2-enoyl)oxy]-4-(trimethylazaniumyl)butanoate

C15H25NO7 (331.163094)


5-hydroxyoct-2-enedioylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyoct-2-enedioic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-hydroxyoct-2-enedioylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-hydroxyoct-2-enedioylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine

4-(4-Fluorophenyl)-3-(4-hydroxy-3-methoxyphenoxymethyl)piperidine

C19H22FNO3 (331.1583634)


   

16alpha, 17-epoxy gibberellin A9

(2R,2R,5R,8R,9S,10R,11S)-11-methyl-16-oxo-15-oxaspiro[oxirane-2,6-pentacyclo[9.3.2.1⁵,⁸.0¹,¹⁰.0²,⁸]heptadecane]-9-carboxylate

C19H23O5- (331.1545408)


16alpha, 17-epoxy gibberellin a9 is also known as 16α, 17-epoxy ga9. 16alpha, 17-epoxy gibberellin a9 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16alpha, 17-epoxy gibberellin a9 can be found in a number of food items such as mugwort, natal plum, radish, and prickly pear, which makes 16alpha, 17-epoxy gibberellin a9 a potential biomarker for the consumption of these food products. 16α, 17-epoxy gibberellin a9 is also known as 16α, 17-epoxy ga9. 16α, 17-epoxy gibberellin a9 is practically insoluble (in water) and a weakly acidic compound (based on its pKa). 16α, 17-epoxy gibberellin a9 can be found in a number of food items such as mugwort, natal plum, radish, and prickly pear, which makes 16α, 17-epoxy gibberellin a9 a potential biomarker for the consumption of these food products.

   

Alitame

3-amino-3-({1-[(2,2,4,4-tetramethylthietan-3-yl)carbamoyl]ethyl}carbamoyl)propanoic acid

C14H25N3O4S (331.15656900000005)


CONFIDENCE standard compound; INTERNAL_ID 5808

   

Ala Ala Gly Asn

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]acetamido}-3-carbamoylpropanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Ala Asn Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]propanamido]-3-carbamoylpropanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Ala Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}propanamido]-3-carbamoylpropanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Gly Gln

(2S)-2-(2-{2-[(2S)-2-aminopropanamido]acetamido}acetamido)-4-carbamoylbutanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Asn Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-3-carbamoylpropanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gly Gln Gly

2-[(2S)-2-{2-[(2S)-2-aminopropanamido]acetamido}-4-carbamoylbutanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Ala Asn Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Ala Asn Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-3-carbamoylpropanamido]acetamido}propanoic acid

C12H21N5O6 (331.14917660000003)


   

Ala Gln Gly Gly

2-{2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]acetamido}acetic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Ala Asn

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]propanamido]-3-carbamoylpropanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Gly Gln

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)propanamido]acetamido}-4-carbamoylbutanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Asn Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-3-carbamoylpropanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Ala Gln Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)propanamido]-4-carbamoylbutanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gly Ala Gln

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]propanamido]-4-carbamoylbutanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gly Gln Ala

(2S)-2-[(2S)-2-[2-(2-aminoacetamido)acetamido]-4-carbamoylbutanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Asn Ala Ala

(2S)-2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]propanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gln Ala Gly

2-[(2S)-2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Gly Gln Gly Ala

(2S)-2-{2-[(2S)-2-(2-aminoacetamido)-4-carbamoylbutanamido]acetamido}propanoic acid

C12H21N5O6 (331.14917660000003)


   

4-(4-Fluorophenyl)-3-(4-methoxy-3-hydroxyphenoxymethyl)piperidine

5-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol

C19H22FNO3 (331.1583634)


   

(-)-tramadol

4-[[4-(4-fluorophenyl)-3-piperidinyl]methoxy]-2-methoxy-, (3S-trans)-Phenol

C19H22FNO3 (331.1583634)


   

Asn Ala Ala Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Asn Ala Gly Ala

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]propanamido]acetamido}propanoic acid

C12H21N5O6 (331.14917660000003)


   

Asn Gly Ala Ala

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}propanamido]propanoic acid

C12H21N5O6 (331.14917660000003)


   

Gln Ala Gly Gly

2-{2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]acetamido}acetic acid

C12H21N5O6 (331.14917660000003)


   

Gln Gly Ala Gly

2-[(2S)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}propanamido]acetic acid

C12H21N5O6 (331.14917660000003)


   

Gln Gly Gly Ala

(2S)-2-(2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}acetamido)propanoic acid

C12H21N5O6 (331.14917660000003)


   

N-benzyl-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine

N-benzyl-1-[(4-fluorophenyl)methyl]benzimidazol-2-amine

C21H18FN3 (331.148468)


   

4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate

4-[(3-acetoxypropyl)amino]-2,2-dimethyl-4-oxobutane-1,3-diyl diacetate

C15H25NO7 (331.163094)


   

Esmolol hydrochloride

Esmolol hydrochloride

C16H26ClNO4 (331.15502660000004)


C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists Esmolol hydrochloride is a beta adrenergic receptor blocker.

   

Dibenzepin hydrochloride

11H-Dibenzo[b,e][1,4]diazepin-11-one,10-[2-(dimethylamino)ethyl]-5,10-dihydro-5-methyl-, hydrochloride (1:1)

C18H22ClN3O (331.14513120000004)


C78272 - Agent Affecting Nervous System > C265 - Antidepressant Agent > C94727 - Tricyclic Antidepressant D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents

   

n-tritylglycine methyl ester

n-tritylglycine methyl ester

C22H21NO2 (331.1572206)


   
   

1-Benzyl-4-(piperidin-4-yl)piperazine dihydrochloride

1-Benzyl-4-(piperidin-4-yl)piperazine dihydrochloride

C16H27Cl2N3 (331.15819220000003)


   

1-(4-TOLUENENSULFONYLAMINO)-2,6-DIISOPROPYLBENZENE

1-(4-TOLUENENSULFONYLAMINO)-2,6-DIISOPROPYLBENZENE

C19H25NO2S (331.160591)


   

PROPIONYLCHOLINE P-TOLUENESULFONATE

PROPIONYLCHOLINE P-TOLUENESULFONATE

C15H25NO5S (331.14533600000004)


   

Benzenemethanamine,N-[bis(4-methoxyphenyl)methylene]-

Benzenemethanamine,N-[bis(4-methoxyphenyl)methylene]-

C22H21NO2 (331.1572206)


   

Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid)

Anastrozole IMpurity (alfa1 , alfa1, alfa3, alfa3-TetraMethyl-5-(1H-1,2,4-triazol-1-ylMethyl)-1,3-Benzenediacetic acid)

C17H21N3O4 (331.15319860000005)


   

2-Isopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

2-Isopropoxy-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-6-(trifluoromethyl)pyridine

C15H21BF3NO3 (331.15665020000006)


   

(R)-8-(Diphenylphosphino)-1,2,3,4-tetrahydronaphthalen-1-amine

(R)-8-(Diphenylphosphino)-1,2,3,4-tetrahydronaphthalen-1-amine

C22H22NP (331.14897820000004)


   
   
   
   

2-Hydroxy-5-[4-(2-hydroxy-ethyl)-piperidin-1-YL]-5-phenyl-1H-pyrimidine-4,6-dione

2-Hydroxy-5-[4-(2-hydroxy-ethyl)-piperidin-1-YL]-5-phenyl-1H-pyrimidine-4,6-dione

C17H21N3O4 (331.15319860000005)


   

N-1H-imidazol-2-yl-N-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine

N-1H-imidazol-2-yl-N-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine

C18H17N7 (331.1545362)


   

(5-Phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol

(5-Phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol

C19H17N5O (331.1433032)


   

6-([5-Quinolylamino]methyl)-2,4-diamino-5-methylpyrido[2,3-D]pyrimidine

6-([5-Quinolylamino]methyl)-2,4-diamino-5-methylpyrido[2,3-D]pyrimidine

C18H17N7 (331.1545362)


   
   

carlactone carboxylate

carlactone carboxylate

C19H23O5- (331.1545408)


   

(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5S,8S,9S,10R,11S)-5-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545408)


   

(1R,2R,5R,8R,9S,10R,11S,13R)-13-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5R,8R,9S,10R,11S,13R)-13-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545408)


   

(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

(1R,2R,5R,8R,9S,10R,11R,12S)-12-hydroxy-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.15,8.01,10.02,8]heptadecane-9-carboxylate

C19H23O5- (331.1545408)


   

16alpha, 17-epoxy GA9

16alpha, 17-epoxy GA9

C19H23O5- (331.1545408)


   

(-)-trans-4-[4-(4-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite)

(-)-trans-4-[4-(4-Fluorophenyl)-3-piperidinylmethoxy]-2-methoxyphenol(Paroxetine metabolite)

C19H22FNO3 (331.1583634)


   

6-Hydroxyoct-2-enedioylcarnitine

6-Hydroxyoct-2-enedioylcarnitine

C15H25NO7 (331.163094)


   

6-Hydroxyoct-3-enedioylcarnitine

6-Hydroxyoct-3-enedioylcarnitine

C15H25NO7 (331.163094)


   

7-Hydroxyoct-3-enedioylcarnitine

7-Hydroxyoct-3-enedioylcarnitine

C15H25NO7 (331.163094)


   

7-Hydroxyoct-4-enedioylcarnitine

7-Hydroxyoct-4-enedioylcarnitine

C15H25NO7 (331.163094)


   

5-Hydroxyoct-2-enedioylcarnitine

5-Hydroxyoct-2-enedioylcarnitine

C15H25NO7 (331.163094)


   

N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-4-pyridinecarboxamide

N-(1-ethyl-6-methyl-3-pyrazolo[3,4-b]quinolinyl)-4-pyridinecarboxamide

C19H17N5O (331.1433032)


   

gibberellin A4(1-)

gibberellin A4(1-)

C19H23O5- (331.1545408)


A gibberellin carboxylic acid anion that is the conjugate base of gibberellin A4, obtained by deprotonation of the carboxy group.

   

gibberellin A20(1-)

gibberellin A20(1-)

C19H23O5- (331.1545408)


Conjugate base of gibberellin A20.

   

2-[(6-ethyl-4-methylquinazolin-2-yl)amino]quinazolin-4(1H)-one

2-[(6-ethyl-4-methylquinazolin-2-yl)amino]quinazolin-4(1H)-one

C19H17N5O (331.1433032)


   
   

1-Tert-butyl-5-[(4-ethoxyanilino)methylidene]-1,3-diazinane-2,4,6-trione

1-Tert-butyl-5-[(4-ethoxyanilino)methylidene]-1,3-diazinane-2,4,6-trione

C17H21N3O4 (331.15319860000005)


   

1,7,7-trimethyl-N-(4-nitrophenyl)-2-oxo-4-bicyclo[2.2.1]heptanecarbohydrazide

1,7,7-trimethyl-N-(4-nitrophenyl)-2-oxo-4-bicyclo[2.2.1]heptanecarbohydrazide

C17H21N3O4 (331.15319860000005)


   
   

Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride

Methyl 3-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}propanoate hydrochloride

C16H26ClNO4 (331.15502660000004)


   

(11R)-carlactonoate

(11R)-carlactonoate

C19H23O5- (331.1545408)


   

N(2)-[4-(indol-3-yl)butanoyl]-L-glutamine

N(2)-[4-(indol-3-yl)butanoyl]-L-glutamine

C17H21N3O4 (331.15319860000005)


   

BRL-44408 (maleate)

BRL-44408 (maleate)

C17H21N3O4 (331.15319860000005)


BRL-44408 maleate is an α2A-adrenoceptor antagonist (Ki: 8.5 nM). BRL-44408 maleate has antidepressant and analgesic activity. BRL-44408 also improves cecal ligation puncture (CLP)-induced acute lung injury[1][2].

   

(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-6-methoxypyrazine-2,3,5-triol

(3r,6r)-3-(1h-indol-3-ylmethyl)-6-isopropyl-6-methoxypyrazine-2,3,5-triol

C17H21N3O4 (331.15319860000005)


   

3-(1h-indol-3-ylmethyl)-6-isopropyl-6-methoxypyrazine-2,3,5-triol

3-(1h-indol-3-ylmethyl)-6-isopropyl-6-methoxypyrazine-2,3,5-triol

C17H21N3O4 (331.15319860000005)